UPDATE 1-Tetraphase antibiotic may reach up to $700 mln in annual sales: CEO
February 08, 2017 at 18:22 PM EST
NEW YORK, Feb 8 (Reuters) - Tetraphase Pharmaceuticals Inc Chief Executive Guy Macdonald said annual sales of the company's lead experimental antibiotic for serious bacterial infections could climb as high as $700 million if approved.
